TapewireFind a company

person · Reporting owner

Laube Lynne Marie

Disclosed activity across 3 companies

Tapewire entity
44108
SEC CIK
0001730687

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Aeries Technology, Inc.WWAC · Entity 7328DirectorOctober 19, 2021October 19, 2021
Cardlytics, Inc.CDLX · Entity 7603DirectorNovember 08, 2022November 10, 2022
NERDWALLET, INC.NRDS · Entity 2280DirectorMay 21, 2026May 26, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Aeries Technology, Inc.

Report date October 19, 2021 · Filed October 19, 2021

This filing explicitly reported no securities owned.

Cardlytics, Inc.

Report date November 08, 2022 · Filed November 10, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect313,547 Reported balance After 2022-11-08 transaction · row 1
1 source row

Row 1 · 2022-11-08 · Sale · Disposed 4 · Balance 313,547

F1: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022.

Common StockSEC Table I · non-derivativeIndirectSee Footnote14,565 Reported balance Holding disclosure · report date 2022-11-08 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 14,565

F2: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.

Common StockSEC Table I · non-derivativeIndirectSee Footnote14,565 Reported balance Holding disclosure · report date 2022-11-08 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 14,565

F3: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.

Filing footnotes · ownership attribution and instrument terms

F1: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022.

F2: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.

F3: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.

NERDWALLET, INC.

Report date May 21, 2026 · Filed May 26, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect79,627 Reported balance After 2026-05-21 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-05-21 · Grant · Acquired 19,494 · Balance 79,627

F1: Represents Restricted Stock Units ("RSUs") payable solely in Class A Common Stock of the Issuer.

F2: Includes 19,494 RSUs payable solely in Class A Common Stock of the Issuer.

Filing footnotes · ownership attribution and instrument terms

F1: Represents Restricted Stock Units ("RSUs") payable solely in Class A Common Stock of the Issuer.

F2: Includes 19,494 RSUs payable solely in Class A Common Stock of the Issuer.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 21, 2026 Filed May 26, 2026 23:03 UTC NERDWALLET, INC. NRDS · Entity 2280 GrantClass A Common Stock 19,494 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-038288 · wk-form4_1779836624.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,627

F1 · shares: Represents Restricted Stock Units ("RSUs") payable solely in Class A Common Stock of the Issuer.

F2 · balance_after: Includes 19,494 RSUs payable solely in Class A Common Stock of the Issuer.

Read SEC document
May 21, 2025 Filed May 23, 2025 22:35 UTC NERDWALLET, INC. NRDS · Entity 2280 GrantClass A Common Stock 18,137 $0.00 $0.00
Disclosure

SEC source: 0001625278-25-000079 · wk-form4_1748039697.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,133

F1 · shares: Represents Restricted Stock Units ("RSUs") payable solely in Class A Common Stock of the Issuer.

F2 · balance_after: Includes 18,137 RSUs payable solely in the Class A Common Stock of the Issuer.

Read SEC document
May 14, 2024 Filed May 16, 2024 21:27 UTC NERDWALLET, INC. NRDS · Entity 2280 GrantClass A Common Stock 11,061 $0.00 $0.00
Disclosure

SEC source: 0001625278-24-000116 · wk-form4_1715894840.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,996

F1 · shares: Represents Restricted Stock Units (RSUs) payable solely in Class A Common Stock of the Issuer.

F2 · balance_after: Includes 11,061 Restricted Stock Units ("RSUs") payable solely in the Class A Common Stock of the Issuer.

Read SEC document
May 24, 2023 Filed May 26, 2023 21:28 UTC NERDWALLET, INC. NRDS · Entity 2280 GrantClass A Common Stock 15,120 $0.00 $0.00
Disclosure

SEC source: 0001625278-23-000075 · wk-form4_1685136500.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,935

F1 · shares: Represents Restricted Stock Units payable solely in Class A Common Stock of the Issuer.

F2 · balance_after: Includes 15,120 Restricted Stock Units payable solely in Class A Common Stock of the Issuer.

Read SEC document
November 08, 2022 Filed Nov 8, 2022 21:49 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 352 $3.98 $1,402.61
Disclosure

SEC source: 0001666071-22-000140 · wf-form4_166794416978301.xml · nonDerivative · entry 2

Laube Lynne Marie · CIK 0001730687 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,551

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022.

Read SEC document
November 08, 2022 Filed Nov 10, 2022 22:01 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 4 $3.93 $15.72
Disclosure

SEC source: 0001666071-22-000146 · wf-form4_166811767013095.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,547

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022.

Read SEC document
November 07, 2022 Filed Nov 8, 2022 21:49 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 6,430 $4.32 $27,777.60
Disclosure

SEC source: 0001666071-22-000140 · wf-form4_166794416978301.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,903

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022.

F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.16 to $4.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 06, 2022 Filed Nov 3, 2022 20:11 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 14,062 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000136 · wf-form4_166750627252014.xml · derivative · entry 4

Laube Lynne Marie · CIK 0001730687 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,062 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "October Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the October Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the October Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 12 months after the October Certification.

F5 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "October Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the October Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the October Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 12 months after the October Certification.

Read SEC document
October 06, 2022 Filed Nov 3, 2022 20:11 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 14,062 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000136 · wf-form4_166750627252014.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
August 05, 2022 Filed Aug 8, 2022 20:40 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 6,612 $15.19 $100,436.28
Disclosure

SEC source: 0001666071-22-000111 · wf-form4_165999119173439.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 306,271

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on June 9, 2022.

F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.88 to $15.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) to this Form 4.

Read SEC document
June 10, 2022 Filed Jun 14, 2022 00:06 UTC Cardlytics, Inc. CDLX · Entity 7603 GiftCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000079 · wf-form4_165516515416665.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,820

F1 · price: Shares transferred by the Reporting Person as a bona fide gift without consideration.

F2 · balance_after: Includes 290 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan.

Read SEC document
June 09, 2022 Filed Jul 20, 2022 21:11 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 14,063 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000097 · wf-form4_165835149544902.xml · derivative · entry 4

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,062

Underlying: Common Stock · 14,063 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

F5 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

Read SEC document
June 09, 2022 Filed Jul 20, 2022 21:11 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 14,063 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000097 · wf-form4_165835149544902.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 312,883

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
May 25, 2022 Filed May 26, 2022 21:52 UTC NERDWALLET, INC. NRDS · Entity 2280 GrantClass A Common Stock 15,815 $0.00 $0.00
Disclosure

SEC source: 0001625278-22-000075 · wf-form4_165360191237899.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,815

F1 · shares: Represents Restricted Stock Units payable solely in Class A Common Stock of the Issuer.

Read SEC document
May 05, 2022 Filed May 9, 2022 20:10 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 17,973 $33.60 $603,892.80
Disclosure

SEC source: 0001666071-22-000062 · wf-form4_165212701709113.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 358,530

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 24, 2022, April 1, 2022 and April 5, 2022 and performance stock units that vested on April 6, 2022.

F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $33.30 to $33.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
April 06, 2022 Filed Apr 7, 2022 23:25 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 14,063 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000039 · wf-form4_164937388406931.xml · derivative · entry 6

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,062

Underlying: Common Stock · 14,063 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F7 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

F7 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

Read SEC document
April 06, 2022 Filed Apr 7, 2022 23:25 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 14,063 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000039 · wf-form4_164937388406931.xml · nonDerivative · entry 2

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 376,503

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
April 05, 2022 Filed Apr 7, 2022 23:25 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Unit · Derivative 6,622 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000039 · wf-form4_164937388406931.xml · derivative · entry 5

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,868

Underlying: Common Stock · 6,622 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F5 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F5 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
April 05, 2022 Filed Apr 7, 2022 23:25 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 6,622 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000039 · wf-form4_164937388406931.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 362,440

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 20:56 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Unit · Derivative 20,161 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000035 · wf-form4_164919213292914.xml · derivative · entry 4

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,322

Underlying: Common Stock · 20,161 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F5 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F5 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 20:56 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 20,161 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000035 · wf-form4_164919213292914.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,818

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
March 24, 2022 Filed Mar 24, 2022 23:55 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantCommon Stock 2,766 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000031 · wf-form4_164816608363968.xml · nonDerivative · entry 2

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,657

F2 · shares: Represents a restricted stock unit ("RSU") award. The shares underlying the RSU award vested immediately upon grant.

Read SEC document
March 22, 2022 Filed Mar 24, 2022 23:55 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantRestricted Stock Unit · Derivative 63,233 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000031 · wf-form4_164816608363968.xml · derivative · entry 5

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,293

Underlying: Common Stock · 63,233 shares

Expires not disclosed

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F6 · derivative.exercise_date: 25% of the RSUs shall vest on April 1, 2023 with the remainder vesting in equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F6 · derivative.expiration_date: 25% of the RSUs shall vest on April 1, 2023 with the remainder vesting in equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
March 07, 2022 Filed Mar 24, 2022 23:55 UTC Cardlytics, Inc. CDLX · Entity 7603 GiftCommon Stock 1,112 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000031 · wf-form4_164816608363968.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,891

F1 · price: Shares transferred by the Reporting Person as a bona fide gift without consideration.

Read SEC document
December 10, 2021 Filed Dec 13, 2021 21:18 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 1,100 $69.36 $76,296.00
Disclosure

SEC source: 0001666071-21-000239 · wf-form4_163943031241318.xml · nonDerivative · entry 4

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,517

F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on December 9, 2021.

F6 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $69.11 to $69.66, inclusive.

Read SEC document
December 10, 2021 Filed Dec 13, 2021 21:18 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 7,432 $68.63 $510,058.16
Disclosure

SEC source: 0001666071-21-000239 · wf-form4_163943031241318.xml · nonDerivative · entry 3

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,617

F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on December 9, 2021.

F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $68.11 to $69.10, inclusive.

Read SEC document
December 10, 2021 Filed Dec 13, 2021 21:18 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 4,544 $67.62 $307,265.28
Disclosure

SEC source: 0001666071-21-000239 · wf-form4_163943031241318.xml · nonDerivative · entry 2

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,049

F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on December 9, 2021.

F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $67.11 to $68.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (5) and (6) to this Form 4.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 21:18 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 28,125 $0.00 $0.00
Disclosure

SEC source: 0001666071-21-000239 · wf-form4_163943031241318.xml · derivative · entry 8

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,125

Underlying: Common Stock · 28,125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F9 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

F9 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 21:18 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantPerformance Stock Unit · Derivative 56,250 $0.00 $0.00
Disclosure

SEC source: 0001666071-21-000239 · wf-form4_163943031241318.xml · derivative · entry 7

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,250

Underlying: Common Stock · 56,250 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F9 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

F9 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 21:18 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 28,125 $0.00 $0.00
Disclosure

SEC source: 0001666071-21-000239 · wf-form4_163943031241318.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · balance_after: Includes 1 share of Common Stock acquired under the Issuer's Employee Stock Purchase Plan.

Read SEC document
December 03, 2021 Filed Dec 20, 2021 21:42 UTC Cardlytics, Inc. CDLX · Entity 7603 GiftCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001666071-21-000246 · wf-form4_164003656128520.xml · nonDerivative · entry 2

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 334,003

Read SEC document
November 05, 2021 Filed Nov 8, 2021 22:29 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 911 $92.95 $84,677.45
Disclosure

SEC source: 0001666071-21-000226 · wf-form4_163641056134204.xml · nonDerivative · entry 4

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,467

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021.

F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $92.90 to $93.00, inclusive.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 22:29 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 800 $92.26 $73,808.00
Disclosure

SEC source: 0001666071-21-000226 · wf-form4_163641056134204.xml · nonDerivative · entry 3

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 324,378

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021.

F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $91.85 to $92.79, inclusive.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 22:29 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 603 $90.88 $54,800.64
Disclosure

SEC source: 0001666071-21-000226 · wf-form4_163641056134204.xml · nonDerivative · entry 2

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,178

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $90.54 to $91.39, inclusive.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 22:29 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 10,676 $90.23 $963,295.48
Disclosure

SEC source: 0001666071-21-000226 · wf-form4_163641056134204.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,781

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021.

F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $89.52 to $90.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.

Read SEC document
October 06, 2021 Filed Oct 6, 2021 22:08 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 28,125 $0.00 $0.00
Disclosure

SEC source: 0001666071-21-000196 · wf-form4_163355809794181.xml · derivative · entry 5

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,125

Underlying: Common Stock · 28,125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

F5 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

Read SEC document
October 06, 2021 Filed Oct 6, 2021 22:08 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantPerformance Stock Unit · Derivative 56,250 $0.00 $0.00
Disclosure

SEC source: 0001666071-21-000196 · wf-form4_163355809794181.xml · derivative · entry 4

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,250

Underlying: Common Stock · 56,250 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

F5 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

Read SEC document
October 06, 2021 Filed Oct 6, 2021 22:08 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 28,125 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-21-000196 · wf-form4_163355809794181.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 336,457

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

F2 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
September 03, 2021 Filed Dec 20, 2021 21:42 UTC Cardlytics, Inc. CDLX · Entity 7603 GiftCommon Stock 514 $0.00 $0.00
Disclosure

SEC source: 0001666071-21-000246 · wf-form4_164003656128520.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,003

Read SEC document
July 15, 2021 Filed Jul 16, 2021 20:50 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 2,138 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001666071-21-000148 · wf-form4_162646861487045.xml · derivative · entry 14

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,887

Underlying: Common Stock · 2,138 shares

Expires 2026-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.

F11 · derivative.exercise_date: Fully vested.

Read SEC document
July 15, 2021 Filed Jul 16, 2021 20:50 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 100 $125.56 $12,556.00
Disclosure

SEC source: 0001666071-21-000148 · wf-form4_162646861487045.xml · nonDerivative · entry 10

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,332

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.

Read SEC document
July 15, 2021 Filed Jul 16, 2021 20:50 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 700 $124.95 $87,465.00
Disclosure

SEC source: 0001666071-21-000148 · wf-form4_162646861487045.xml · nonDerivative · entry 9

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,432

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.

F8 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.47 to $125.30, inclusive.

Read SEC document
July 15, 2021 Filed Jul 16, 2021 20:50 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 638 $123.03 $78,493.14
Disclosure

SEC source: 0001666071-21-000148 · wf-form4_162646861487045.xml · nonDerivative · entry 8

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,132

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.

F7 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $122.80 to $123.23, inclusive.

Read SEC document
July 15, 2021 Filed Jul 16, 2021 20:50 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 400 $122.29 $48,916.00
Disclosure

SEC source: 0001666071-21-000148 · wf-form4_162646861487045.xml · nonDerivative · entry 7

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,770

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.

F6 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $121.725 to $122.64, inclusive.

Read SEC document
July 15, 2021 Filed Jul 16, 2021 20:50 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 300 $120.42 $36,126.00
Disclosure

SEC source: 0001666071-21-000148 · wf-form4_162646861487045.xml · nonDerivative · entry 6

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,170

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.

F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $120.07 to $120.66, inclusive.

Read SEC document
July 15, 2021 Filed Jul 16, 2021 20:50 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 2,138 $20.00 $42,760.00
Disclosure

SEC source: 0001666071-21-000148 · wf-form4_162646861487045.xml · nonDerivative · entry 5

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,470

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.

Read SEC document
July 14, 2021 Filed Jul 16, 2021 20:50 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 3,376 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001666071-21-000148 · wf-form4_162646861487045.xml · derivative · entry 13

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,025

Underlying: Common Stock · 3,376 shares

Expires 2026-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.

F11 · derivative.exercise_date: Fully vested.

Read SEC document
July 14, 2021 Filed Jul 16, 2021 20:50 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 300 $125.77 $37,731.00
Disclosure

SEC source: 0001666071-21-000148 · wf-form4_162646861487045.xml · nonDerivative · entry 4

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,332

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.

F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $125.70 to $125.90, inclusive.

Read SEC document
July 14, 2021 Filed Jul 16, 2021 20:50 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 1,100 $124.56 $137,016.00
Disclosure

SEC source: 0001666071-21-000148 · wf-form4_162646861487045.xml · nonDerivative · entry 3

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,632

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.15 to $124.895, inclusive.

Read SEC document
July 14, 2021 Filed Jul 16, 2021 20:50 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 1,976 $123.77 $244,569.52
Disclosure

SEC source: 0001666071-21-000148 · wf-form4_162646861487045.xml · nonDerivative · entry 2

Laube Lynne Marie · CIK 0001730687 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,732

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.

F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $123.14 to $124.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7) and (8) to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.